Literature DB >> 22047137

Low concentrations of honey reduce biofilm formation, quorum sensing, and virulence in Escherichia coli O157:H7.

Jin-Hyung Lee1, Joo-Hyeon Park, Jung-Ae Kim, Ganesh Prasad Neupane, Moo Hwan Cho, Chang-Soo Lee, Jintae Lee.   

Abstract

Bacterial biofilms are associated with persistent infections due to their high resistance to antimicrobial agents. Hence, controlling pathogenic biofilm formation is important in bacteria-related diseases. Honey, at a low concentration of 0.5% (v/v), significantly reduced biofilm formation in enterohemorrhagic Escherichia coli O157:H7 without inhibiting the growth of planktonic cells. Conversely, this concentration did not inhibit commensal E. coli K-12 biofilm formation. Transcriptome analyses showed that honey significantly repressed curli genes (csgBAC), quorum sensing genes (AI-2 importer and indole biosynthesis), and virulence genes (LEE genes). Glucose and fructose in the honeys were found to be key components in reducing biofilm formation by E. coli O157:H7 through the suppression of curli production and AI-2 import. Furthermore, honey, glucose and fructose decreased the colonization of E. coli O157:H7 cells on human HT-29 epithelial cells. These results suggest that low concentrations of honey, such as in honeyed water, can be a practical means for reducing the colonization and virulence of pathogenic E. coli O157:H7.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22047137     DOI: 10.1080/08927014.2011.633704

Source DB:  PubMed          Journal:  Biofouling        ISSN: 0892-7014            Impact factor:   3.209


  21 in total

Review 1.  Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.

Authors:  David Lebeaux; Jean-Marc Ghigo; Christophe Beloin
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

Review 2.  Strategies for Biofilm Inhibition and Virulence Attenuation of Foodborne Pathogen-Escherichia coli O157:H7.

Authors:  Sandra Folarin Oloketuyi; Fazlurrahman Khan
Journal:  Curr Microbiol       Date:  2017-07-25       Impact factor: 2.188

Review 3.  Biofilm Management in Wound Care.

Authors:  Chandan K Sen; Sashwati Roy; Shomita S Mathew-Steiner; Gayle M Gordillo
Journal:  Plast Reconstr Surg       Date:  2021-08-01       Impact factor: 5.169

4.  Evolution of honey resistance in experimental populations of bacteria depends on the type of honey and has no major side effects for antibiotic susceptibility.

Authors:  Anna M Bischofberger; Katia R Pfrunder Cardozo; Michael Baumgartner; Alex R Hall
Journal:  Evol Appl       Date:  2021-03-10       Impact factor: 5.183

5.  Honey: A Therapeutic Agent for Disorders of the Skin.

Authors:  Pauline McLoone; Afolabi Oluwadun; Mary Warnock; Lorna Fyfe
Journal:  Cent Asian J Glob Health       Date:  2016-08-04

Review 6.  Honey as a Complementary Medicine.

Authors:  M G Miguel; M D Antunes; M L Faleiro
Journal:  Integr Med Insights       Date:  2017-04-24

Review 7.  Honey as a Potential Natural Antioxidant Medicine: An Insight into Its Molecular Mechanisms of Action.

Authors:  Sarfraz Ahmed; Siti Amrah Sulaiman; Atif Amin Baig; Muhammad Ibrahim; Sana Liaqat; Saira Fatima; Sadia Jabeen; Nighat Shamim; Nor Hayati Othman
Journal:  Oxid Med Cell Longev       Date:  2018-01-18       Impact factor: 6.543

Review 8.  Development of quorum-based anti-virulence therapeutics targeting Gram-negative bacterial pathogens.

Authors:  Song Buck Tay; Wen Shan Yew
Journal:  Int J Mol Sci       Date:  2013-08-09       Impact factor: 5.923

9.  Effects of Selected Egyptian Honeys on the Cellular Ultrastructure and the Gene Expression Profile of Escherichia coli.

Authors:  Reham Wasfi; Walid F Elkhatib; Ahmed S Khairalla
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

Review 10.  Therapeutic Manuka Honey: No Longer So Alternative.

Authors:  Dee A Carter; Shona E Blair; Nural N Cokcetin; Daniel Bouzo; Peter Brooks; Ralf Schothauer; Elizabeth J Harry
Journal:  Front Microbiol       Date:  2016-04-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.